test

Mark McDonnell

@Arch Venture Management, Llc

Latest period2024 - Q3ReportedManaged Assets$260.56MTotal holdings9
Assets growth rate-2.05%Assets growth rate (2-Q avg)114.67%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Arch Venture Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 9 positions.

Assets under management

The assets under management (AUM) of Arch Venture Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 260.56M in assets, with a quarterly growth rate of -2.05% and a 2-quarter average growth rate of 114.67%. The portfolio is managed by Mark McDonnell, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
BEAMBeam Therapeutics Inc.
Recent Activity
Decreased -11.17%
45.46%
$118.449M
4.835M shares@ $24.51 avg price
RAPPRapport Therapeutics, Inc.
Recent Activity
29.31%
$76.365M
3.729M shares@ $20.48 avg price
ERASErasca, Inc.
Recent Activity
11.59%
$30.182M
11.056M shares@ $2.73 avg price
QTTBQ32 Bio Inc.
Recent Activity
5.49%
$14.3M
320,482 shares@ $44.63 avg price
VERVVerve Therapeutics, Inc.
Recent Activity
3.74%
$9.723M
2.009M shares@ $4.85 avg price
GOSSGossamer Bio, Inc.
Recent Activity
3.05%
$7.946M
8.056M shares@ $0.99 avg price
OMICSingular Genomics Systems, Inc.
Recent Activity
0.77%
$1.984M
126,630 shares@ $15.67 avg price
UBXUnity Biotechnology, Inc.
Recent Activity
0.57%
$1.477M
1.005M shares@ $1.48 avg price
CEROCero Therapeutics Holdings, Inc.
Recent Activity
0.06%
$134,753
1.444M shares@ $0.1 avg price